This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Novo Nordisk A/s. Active years: 2014-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Frederiksberg C., DK (2014)
- Frederiksberg C, DK (2014 - 2015)
- Frederiksberg, DK (2021)
Company Filing History:
Years Active: 2014-2021
Title: Tine Nygaard Vinther: Innovator in Diabetes Treatment
Introduction
Tine Nygaard Vinther is a prominent inventor based in Frederiksberg, Denmark. She has made significant contributions to the field of diabetes treatment through her innovative work in insulin development. With a total of 4 patents to her name, Tine is recognized for her advancements in pharmaceutical compositions that enhance the efficacy of insulin.
Latest Patents
Tine's latest patents include groundbreaking inventions such as "Insulins with polar recombinant extensions." This invention relates to novel insulins or insulin analogues that are extended with predominantly sequences of polar amino acid residues. The goal is to improve the half-life and stability of the drug substance. Additionally, this invention provides pharmaceutical compositions comprising such drug substances and relates to their use for the treatment or prevention of medical conditions related to diabetes. Another significant patent is "Human insulin analogues and derivatives comprising cysteine substitutions." This invention focuses on human insulin analogues containing a substituting cysteine and human insulin derivatives containing a PEGylated substituting cysteine. These compounds may be useful for the treatment of diabetes.
Career Highlights
Tine Nygaard Vinther works at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. Her role at Novo Nordisk has allowed her to contribute to the development of innovative treatments that improve the lives of individuals with diabetes.
Collaborations
Throughout her career, Tine has collaborated with notable colleagues, including Thomas Boerglum Kjeldsen and Frantisek Hubalek. These collaborations have further enhanced her research and development efforts in the field of diabetes treatment.
Conclusion
Tine Nygaard Vinther is a trailblazer in the field of diabetes treatment, with her innovative patents paving the way for improved insulin therapies. Her work at Novo Nordisk and collaborations with esteemed colleagues highlight her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile